Capital Flow Monitor · Sponsors · CIK 1824034

Avicenna Biosciences, Inc.

101 W. CHAPEL HILL STREET, SUITE 210, DURHAM, NC, 27701 · 919-667-2504

Biotechnology · Corporation· inc. DELAWARE true

Fit score

Offering

$71K

Sold

$71K

% sold

100.0%

Investors

1

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-10-30 D/A ·current 506(b) $71K $71K 100.0% 1 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Christopher Meldrum — Executive Officer / Director, Durham, NC
  • Thomas Kaiser — Executive Officer / Director, Durham, NC
  • Pieter Burger — Executive Officer / Director, Durham, NC
  • John Hamer — Director, Durham, NC
  • Dennis Langer — Director, Durham, NC

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.